Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3(mut) AML

Detalles Bibliográficos
Autores principales: Terao, Toshiki, Matsuoka, Ken-ichi, Ueda, Hiroko, Matsumura, Akifumi, Matsubara, Chisato, Kondo, Kaho, Kondo, Takumi, Fujiwara, Hideaki, Asada, Noboru, Ennishi, Daisuke, Nishimori, Hisakazu, Fujii, Keiko, Fujii, Nobuharu, Maeda, Yoshinobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984958/
https://www.ncbi.nlm.nih.gov/pubmed/36583677
http://dx.doi.org/10.1182/bloodadvances.2022008991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984958/
https://www.ncbi.nlm.nih.gov/pubmed/36583677
http://dx.doi.org/10.1182/bloodadvances.2022008991

Ejemplares similares